GANX

0.99944.82%
HP

Hans Peter Hasler

Independent Director

Mr. Hans Peter Hasler serves as Independent Non Executive Chairman of Shield Therapeutics plc since June 18, 2020. At Shield Therapeutics plc, he also served as Independent Non-Executive Director from July 26, 2018 to June 18, 2020. He serves as Independent Director at Minerva Neurosciences, Inc., which he joined on December 10, 2017. He serves as Chairman of the Board of Directors at HBM Healthcare Investments AG and has also served as a Member of the board of Directors at the firm, which he joined in 2009. He serves as Vice Chairman, President & CEO at Vicarius Pharma AG, which he joined on September 17, 2017. He serves as Independent Director at Gain Therapeutics, Inc., which he joined in 2020. He serves as Principal at HPH Management GmbH, where he also served as Principal from 2010 to 2012. He serves as Global Life Science Advisors at Rigi Healthcare AG since 2014. He serves as a Corporate Advisor to Temasek (Private) Ltd. He serves as Chairman of MIAC AG (Medical Imaging Analysis Center) of the University Hospital since December 2012. He serves as Vice Chairman of Acino Pharma AG since April 2008. He is Founder of Vicarius Pharma Limited AG. He serves as Chief Advisor of SBTech Advisory. He serves as a Member of the Advisory Board of evalueSCIENCE AG. He serves as Director of AOP Orphan Pharmaceuticals AG since 2014. He serves on the Board of Directors of Dr. Reddy’s Laboratories S.A. He served as Additional Independent Director at Dr. Reddy's Laboratories Limited from June 17, 2016 to June 14, 2018. He served as an Independent Non-Executive Director at Patheon N.V. from March 2016 to August 29, 2017. He served as Independent Non-Executive Director at Patheon B.V., where he was employed from March 2016 to August 29, 2017. He served as Chief Operating Officer at Elan Corporation, plc from October 1, 2012 to 2013 and as a Director from September 15, 2011 to October 1, 2012. He served as Chief Operating Officer at Elan Corporation Limited, where he was employed from September 15, 2011 to October 1, 2012. He served as Vice Chairman at Acino Holding AG from April 1, 2010 to April 4, 2013 and as a Director since April 1, 2008. He served as Director at Acino International AG, where he was employed from April 1, 2008 to April 4, 2013. He served as Outside Director of Celltrion, Inc. from September 15, 2011 to October 1, 2012. He served as Director of Ferring Holding SA. He served as Vice Chairman at Santhera Pharmaceuticals Holding AG, where he was employed from October 2006 to October 1, 2011. He also served as Director of the company from October 17, 2006 to October 1, 2011. He served as Executive Chairman of Eidetica Biopharma from November 16, 2007 to May 4, 2010. He served as Chief Operating Officer, Head of International and Executive VP of Global Neurology at Biogen Inc., where he was employed until March 30, 2009. At Biogen Inc., he also served as Chief Operating Officer from May 2008 to March 30, 2009, Head of Global Neurology and Cardiovascular Business in 2007, and Head of Commercial Operations from 2001 to 2003. He served as Executive Vice President of Global Neurology Head of International at Biogen MA Inc. He served as Executive Vice President of Global Neurology and Head of International at Biogen Idec Ma Inc. from October 2007 to March 30, 2009, as Senior Vice President of International Strategic Business Unit from February 2006 to October 2007, and as Executive Vice President of Commercial Operations since August 2001. He served as Senior Vice President and Head of International Organization at Biogen Idec International GmbH from 2004 to 2007. He served as Director at Orexo AB (publ), where he was employed from 2005 to 2008. He served as Senior Vice President and Chief Marketing Officer, Head of Global Strategic Marketing at Wyeth Pharmaceuticals AG from 1998 to 2001. He served as Managing Director of its Swiss, Austrian, Central Eastern Europe and German business at Wyeth Pharmaceuticals from 1993 to 1998. He served as Chief Operating Officer and Executive Vice President at Perrigo Company plc. He served as Executive Officer at Abbott Service AG. He worked at Abbott AG. He served as Executive Officer at Sanofi. He worked at Sanofi Pharma AG. He served as Director of Canyon Pharmaceuticals, Inc. He served as Director of Patheon Inc. He has experience in the industry serving as a global life science advisor to pharmaceutical and biotechnology companies. He holds a Swiss Federal Commercial Diploma from Central Authority of the Canton of Bern, a Diploma in Business Management from Swiss Institute of Business, Zurich, and a Marketing Manager Certificate and degree in Business and Marketing from Swiss Institute of Business and Economics (SIB) in 1993.

Positions